Agile Therapeutics | AGRX - Interest Expense On Debt

Agile Therapeutics reported $1M in Interest Expense on Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Interest Expense On Debt Change
Adma Biologics ADMA:US USD 5.58M 1.01M
Biomarin Pharmaceutical BMRN:US USD 3.63M 1.05M
JAZZ PHA JAZZ:US USD 81.22M 2.52M
Pacira Pharmaceuticals PCRX:US USD 11.04M 1.18M
Pfizer PFE:US USD 313M 2M
Teva Pharmaceutical Industries TEVA:US USD 237M 7M
Therapeuticsmd TXMD:US USD 4.83M 6.86M